Comment
doi: 10.1073/pnas.0606333103.
Epub 2006 Sep 5.
A malleable catalyst dominates the metabolism of drugs
Affiliations
- PMID: 16954196
- PMCID: PMC1564253
- DOI: 10.1073/pnas.0606333103
Item in Clipboard
Comment
A malleable catalyst dominates the metabolism of drugs
Proc Natl Acad Sci U S A.
.
No abstract available
Conflict of interest statement
Conflict of interest statement: No conflicts declared.
Comment on
-
Structural basis for ligand promiscuity in cytochrome P450 3A4.Proc Natl Acad Sci U S A. 2006 Sep 12;103(37):13682-7. doi: 10.1073/pnas.0603236103. Epub 2006 Sep 5. Proc Natl Acad Sci U S A. 2006. PMID: 16954191 Free PMC article.
Similar articles
-
Flexibility of human cytochromes P450: molecular dynamics reveals differences between CYPs 3A4, 2C9, and 2A6, which correlate with their substrate preferences.J Phys Chem B. 2008 Jul 10;112(27):8165-73. doi: 10.1021/jp800311c. Epub 2008 Jun 17. J Phys Chem B. 2008. PMID: 18598011
-
Genetics. SNP-ing drugs to size.Science. 2001 Jul 27;293(5530):595. doi: 10.1126/science.293.5530.595. Science. 2001. PMID: 11474082 No abstract available.
-
In vitro and in vivo drug interactions involving human CYP3A.Annu Rev Pharmacol Toxicol. 1998;38:389-430. doi: 10.1146/annurev.pharmtox.38.1.389. Annu Rev Pharmacol Toxicol. 1998. PMID: 9597161 Review.
-
The 2002 Bernard B. Brodie Award lecture: deciphering substrate recognition by drug-metabolizing cytochromes P450.Drug Metab Dispos. 2003 Dec;31(12):1532-40. doi: 10.1124/dmd.31.12.1532. Drug Metab Dispos. 2003. PMID: 14625350 No abstract available.
-
[Drug metabolism catalyzed by cytochrome P-450].Nihon Yakurigaku Zasshi. 2009 Sep;134(3):146-8. doi: 10.1254/fpj.134.146. Nihon Yakurigaku Zasshi. 2009. PMID: 19749487 Review. Japanese. No abstract available.
Cited by
-
Structural insights on bioremediation of polycyclic aromatic hydrocarbons using microalgae: a modelling-based computational study.Environ Monit Assess. 2018 Jan 22;190(2):92. doi: 10.1007/s10661-017-6459-4. Environ Monit Assess. 2018. PMID: 29356900
-
Impaired hepatic drug and steroid metabolism in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency.Eur J Endocrinol. 2010 Dec;163(6):919-24. doi: 10.1530/EJE-10-0764. Epub 2010 Sep 15. Eur J Endocrinol. 2010. PMID: 20844025 Free PMC article.
-
QM/MM Simulation on P450 BM3 Enzyme Catalysis Mechanism.J Chem Theory Comput. 2009;5(5):1421-1431. doi: 10.1021/ct900040n. J Chem Theory Comput. 2009. PMID: 20046929 Free PMC article.
-
Cholesterol-secreting and statin-responsive hepatocytes from human ES and iPS cells to model hepatic involvement in cardiovascular health.PLoS One. 2013 Jul 11;8(7):e67296. doi: 10.1371/journal.pone.0067296. Print 2013. PLoS One. 2013. PMID: 23874411 Free PMC article.
-
Linear Interaction Energy Based Prediction of Cytochrome P450 1A2 Binding Affinities with Reliability Estimation.PLoS One. 2015 Nov 9;10(11):e0142232. doi: 10.1371/journal.pone.0142232. eCollection 2015. PLoS One. 2015. PMID: 26551865 Free PMC article.
References
-
- Williams JA, Hyland R, Jones BC, Smith DA, Hurst S, Goosen TC, Peterkin V, Koup JR, Ball SE. Drug Metab Dispos. 2004;32:1201–1208. - PubMed
-
- Wienkers LC, Heath TG. Nat Rev Drug Discov. 2005;4:825–833. - PubMed
-
- Guengerich FP. In: Cytochrome P450: Structure, Mechanism, and Biochemistry. Ortiz de Montellano P. R., editor. New York: Kluwer Academic/Plenum; 2005. pp. 377–530.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
